Targeting GPVI and CLEC-2 with fostamatinib as a novel antithrombotic strategy

Project Details

Short titleTargeting GPVI and CLEC-2 with fostamatinib as a novel antithrombotic strategy
StatusActive
Effective start/end date1/12/1831/12/23

Funding

  • RIGEL PHARMACEUTICALS INC